Valder R. Arruda

13.8k total citations · 1 hit paper
126 papers, 7.0k citations indexed

About

Valder R. Arruda is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Valder R. Arruda has authored 126 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Genetics, 64 papers in Hematology and 57 papers in Molecular Biology. Recurrent topics in Valder R. Arruda's work include Virus-based gene therapy research (71 papers), CAR-T cell therapy research (43 papers) and Hemophilia Treatment and Research (41 papers). Valder R. Arruda is often cited by papers focused on Virus-based gene therapy research (71 papers), CAR-T cell therapy research (43 papers) and Hemophilia Treatment and Research (41 papers). Valder R. Arruda collaborates with scholars based in United States, Brazil and Canada. Valder R. Arruda's co-authors include Katherine A. High, Roland W. Herzog, Federico Mingozzi, Timothy C. Nichols, Fernando Ferreira Costa, Linda B. Couto, Benjamin J. Samelson‐Jones, Joyce Maria Annichino‐Bizzacchi, Yilin Liu and Shangzhen Zhou and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and Blood.

In The Last Decade

Valder R. Arruda

124 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

2000 782 citations Mark A. Kay, Roland W. Herzog et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valder R. Arruda United States	45	4.3k	3.8k	2.2k	2.2k	646	126	7.0k
Paul E. Monahan United States	36	2.3k 0.5×	2.3k 0.6×	887 0.4×	1.3k 0.6×	413 0.6×	99	4.2k
Edward F. Srour United States	43	1.1k 0.2×	2.9k 0.8×	1.8k 0.8×	3.0k 1.4×	1.5k 2.4×	165	7.2k
Ansgar Schulz Germany	33	872 0.2×	1.7k 0.5×	986 0.4×	1.1k 0.5×	300 0.5×	122	4.5k
David M. Bodine United States	38	1.9k 0.4×	3.9k 1.0×	837 0.4×	844 0.4×	2.0k 3.0×	97	6.3k
Juan A. Bueren Spain	36	1.5k 0.3×	2.8k 0.7×	960 0.4×	888 0.4×	1.4k 2.2×	181	5.3k
Gerard Wagemaker Netherlands	39	1.1k 0.3×	1.6k 0.4×	883 0.4×	1.5k 0.7×	465 0.7×	146	4.2k
Lambert Busque Canada	35	930 0.2×	2.0k 0.5×	748 0.3×	2.9k 1.4×	1.8k 2.8×	149	5.8k
David B. Miklos United States	37	810 0.2×	1.5k 0.4×	2.2k 1.0×	2.1k 1.0×	777 1.2×	224	6.5k
Colin A. Sieff United States	40	993 0.2×	2.5k 0.7×	1.4k 0.6×	2.4k 1.1×	893 1.4×	90	6.1k
Tobias Gedde‐Dahl Norway	39	1.0k 0.2×	1.8k 0.5×	770 0.3×	1.0k 0.5×	651 1.0×	225	5.3k

Countries citing papers authored by Valder R. Arruda

Since Specialization

Citations

This map shows the geographic impact of Valder R. Arruda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valder R. Arruda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valder R. Arruda more than expected).

Fields of papers citing papers by Valder R. Arruda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valder R. Arruda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valder R. Arruda. The network helps show where Valder R. Arruda may publish in the future.

Co-authorship network of co-authors of Valder R. Arruda

This figure shows the co-authorship network connecting the top 25 collaborators of Valder R. Arruda. A scholar is included among the top collaborators of Valder R. Arruda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valder R. Arruda. Valder R. Arruda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Arruda, Valder R., David Lillicrap, & Roland W. Herzog. (2022). Immune complications and their management in inherited and acquired bleeding disorders. Blood. 140(10). 1075–1085. 10 indexed citations

2.

Samelson‐Jones, Benjamin J. & Valder R. Arruda. (2020). Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A. Frontiers in Immunology. 11. 618–618. 30 indexed citations

3.

Arruda, Valder R., Bhavya S. Doshi, & Benjamin J. Samelson‐Jones. (2017). Novel approaches to hemophilia therapy: successes and challenges. Blood. 130(21). 2251–2256. 92 indexed citations

4.

Nichols, Timothy C., et al.. (2015). Translational Data from Adeno-Associated Virus-Mediated Gene Therapy of Hemophilia B in Dogs. PubMed. 26(1). 5–14. 27 indexed citations

5.

Arruda, Valder R., et al.. (2015). Obstacles and future of gene therapy for hemophilia. Expert Opinion on Orphan Drugs. 3(9). 997–1010. 26 indexed citations

6.

Ozelo, Margareth C., B. Vidal, Christine Brown, et al.. (2014). Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response. Blood. 123(26). 4045–4053. 23 indexed citations

7.

Nichols, Timothy C., et al.. (2014). Translational Data from AAV-Mediated Gene Therapy of Hemophilia B in Dogs. 776275620–776275620. 4 indexed citations

8.

Sabatino, Denise E. & Valder R. Arruda. (2013). Muscle Gene Therapy for Hemophilia. Journal of Genetic Syndromes & Gene Therapy. S1(2). 4 indexed citations

9.

Ivanciu, Lacramioara, Raffaella Toso, Paris Margaritis, et al.. (2011). A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia. Nature Biotechnology. 29(11). 1028–1033. 62 indexed citations

10.

Li, Hojun, Nirav Malani, Alexander Schlachterman, et al.. (2010). Assessing the potential for AAV vector genotoxicity in a murine model. Blood. 117(12). 3311–3319. 190 indexed citations

11.

Haurigot, Virginia, Federico Mingozzi, George Buchlis, et al.. (2010). Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs. Molecular Therapy. 18(7). 1318–1329. 52 indexed citations

12.

Paula, Erich Vinícius De, et al.. (2009). Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemia. Translational research. 153(5). 232–239. 11 indexed citations

13.

Favaro, Patrícia, Jin Zhou, J. Fraser Wright, et al.. (2009). Host and Vector-dependent Effects on the Risk of Germline Transmission of AAV Vectors. Molecular Therapy. 17(6). 1022–1030. 31 indexed citations

14.

Paula, Erich Vinícius De, Celso Darío Ramos, Margareth C. Ozelo, et al.. (2006). Early in vivo anticoagulation inhibits the angiogenic response following hindlimb ischemia in a rodent model. Thrombosis and Haemostasis. 96(7). 68–72. 4 indexed citations

15.

Margaritis, Paris, et al.. (2004). Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. Journal of Clinical Investigation. 113(7). 1025–1031. 3 indexed citations

16.

Margaritis, Paris, et al.. (2004). Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. Journal of Clinical Investigation. 113(7). 1025–1031. 55 indexed citations

17.

Voetsch, Barbara, Alfredo Damasceno, Joyce Maria Annichino‐Bizzacchi, Valder R. Arruda, & Joseph Loscalzo. (2001). Paraoxonase Polymorphisms and the Risk of Arterial Ischemic Stroke among Young Adults. Stroke. 32. 331–331. 1 indexed citations

18.

Arruda, Valder R., Carmen Sílvia Passos Lima, Irene Lorand‐Metze, et al.. (2001). Increased risk for acute myeloid leukaemia in individuals with glutathione S‐transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. European Journal Of Haematology. 66(6). 383–388. 67 indexed citations

19.

Arruda, Valder R., Lúcia H. Siqueira, Manoel C.P. Soares, et al.. (1998). Prevalence of the mutation C677 ? T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. American Journal of Medical Genetics. 78(4). 332–335. 79 indexed citations

20.

Arruda, Valder R. & Joyce Maria Annichino‐Bizzacchi. (1996). High-dose dexamethasone therapy in chronic idiopathic thrombocytopenic purpura. Annals of Hematology. 73(4). 175–177. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact